Similarly, in PD, O-GlcNAcylation of NEK7 at Thr170/Thr172 inhibits its interaction with NLRP3, thereby blocking the NEK7/NLRP3 pathway and potentially mitigating disease progression (145). Here, NLRP3 is linked to Parkinson disease.